Related Experiment Video
Updated: Nov 15, 2025

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
Published on: June 6, 2025
SARS-CoV-2 (COVID-19): Beginning to Understand a New Virus
Giau Van Vo1,2,3, Eva Bagyinszky1,2, Yoon Soo Park4
1Department of Industrial and Environmental Engineering, Graduate School of Environment, Gachon University, Seongnam-si, Gyeonggi-do, South Korea.
The COVID-19 pandemic, caused by SARS-CoV-2, necessitates urgent development of new medications and diagnostic tools. This review explores strategies to mitigate infections and prepare for future waves.
Area of Science:
- Virology and Epidemiology
- Public Health and Policy
Background:
- Coronaviridae family members have shown epidemic potential in recent decades.
- Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), causing COVID-19, emerged in late 2019.
- Rapid global spread of COVID-19 has led to significant mortality rates.
Purpose of the Study:
- To review current challenges and needs for COVID-19 mitigation.
- To highlight the urgency for alternative medications and diagnostic strategies.
- To inform policy decisions regarding lifting restrictions and preventing secondary waves.
Main Methods:
- Literature review of scientific publications on COVID-19.
- Analysis of epidemiological data and mortality rates.
- Synthesis of information on therapeutic and diagnostic advancements.
Main Results:
- Global mortality rate for COVID-19 is currently 6.6%.
- Governmental restrictions on gatherings are primary mitigation measures.
- Significant need exists for novel medical interventions.
Conclusions:
- Effective containment of COVID-19 requires advanced medical countermeasures.
- Development of alternative medications and diagnostics is critical for public health.
- Strategic planning is essential to manage potential future waves of infection.
More Related Videos
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
10:25Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
Related Concept Videos
Viruses with RNA Genomes
Viral Mutations
What are Viruses?
Introduction to Virus
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...